Becton, Dickinson & Co. expands the Class I recall of millions of its Q-Syte Luer access intravenous systems to include its Nexiva IV catheter.
Becton, Dickinson & Co. (NYSE:BDX) voluntarily expanded the Class I recall of millions of its Q-Syte Luer access devices to include its Nexiva intravenous catheter systems.
The recall, initiated last October, was prompted by complaints that air was introduced in to device through its septum's bottom disk, potentially leading to air embolisms or leakage that could cause serious injury or death. The Nexiva devices contain two of the Q-Syte components containing the defect, which was caused by a "manufacturing deviation," BD said.
The defect occurred in about 2.8 million BD Q-Syte and 2.9 million BD Nexiva units containing 5 million BD Q-Syte devices distributed from November 2008 to November 2009 in the U.S., Asia, Canada, Europe, Mexico, the Middle East, South Africa and South America. BD said it corrected the problem and expects the recall to have a negligible effect on its books.
The recall affects the following catalog and lot numbers:
A special panel convened by the Food & Drug Administration narrowly cleared Medtronic's...
Boston Scientific Corp.'s stock dips on news that it's holding all shipment of its...
Hopkinton, Mass.-based lab equipment and services provider Caliper Life Sciences reaches a settlement...
Medtronic Inc. launches a 1,000-patient study of its CoreValve aortic stenosis therapy, designed as a...
Taunton, Mass.-based OMNIlife Science Inc. will be the exclusive distributor of hip articulation...